Late-effect radiation tissue damage is one of the strongest evidence cases for HBOT in modern medicine. The FDA approved it. See the late radiation tissue injury evidence atlas for the full study-by-study evidence breakdown.
Medicare covers it. The Undersea and Hyperbaric Medical Society rates it a top-tier indication.
That makes this article different from most HBOT content. It is not a list of marketing claims set against weak evidence. It is a summary of real clinical research backing a real medical use.
The FDA has cleared HBOT for 13 specific uses. Delayed radiation injury is one of them, covering both soft-tissue and bone effects.
For most other off-label HBOT uses, we are skeptical. For this one, the evidence holds up.
What radiation tissue damage is
Radiation therapy is used in roughly half of all cancer patients at some point (NCI 2019). The radiation harms cancer cells but also damages nearby healthy tissue.
Most damage heals. In a minority of cases, healing fails. The damaged tissue becomes hypoxic, fibrotic, and prone to chronic ulceration or fracture.
This late effect can appear months to years after the first treatment. The medical term is "delayed radiation injury" when soft tissue is hurt, or "bone radionecrosis" when bone is hurt.
Common sites are head and neck (after H&N cancer rays), pelvis (after prostate or cervical), and chest wall (after breast cancer). The Marx grade is the most-used system (Marx 1983).
How HBOT helps
The mechanism is well known. Tissue with low oxygen cannot heal. HBOT raises tissue oxygen levels enough to restart blood vessel growth and cell repair.
A study by Marx 1990 measured tissue oxygen tension in irradiated mandibles before and after HBOT. Pre-HBOT levels were below 5 mmHg in the worst zones. Post-HBOT levels rose toward normal range and stayed elevated for weeks.
This is not the same loose story you hear for off-label HBOT uses. Tissue oxygen readings are real numbers. The blood vessel response repeats across studies.
The standard protocol is 30 to 40 sessions at 2.0 to 2.4 ATA, 90 minutes per session, five days a week. For dental or surgical procedures in irradiated tissue, a perioperative protocol of 20 pre-op sessions and 10 post-op sessions is common (Marx 1985).
The evidence base
Several randomized controlled trials support HBOT for radiation tissue damage. We summarize the major ones below.
The Bennett et al. 2016 Cochrane review pooled data from 14 RCTs. It found significant improvement in late radiation tissue injury healing with HBOT compared to controls.
The HOPON trial (2019) tested HBOT for preventing bone injury after dental work in patients with prior radiation. The results were mixed.
HBOT did not reduce bone injury rates in this prevention setting. That sharpened the focus on HBOT as a treatment for sick tissue rather than a prevention tool.
DAHANCA-21 (2018) tested HBOT plus surgery vs surgery alone for jaw bone injury. The trial closed early because too few patients signed up, but the trend favored HBOT.
The Clarke et al. 2008 trial on pelvic radiation injury found that 80% of HBOT-treated patients had clinical improvement vs 30% of controls (n=120, randomized).
The evidence is not uniformly positive. The HOPON trial in particular showed where HBOT does not help. That kind of negative result strengthens, not weakens, the field — because it tells us when to use it and when not to.
What UHMS and other bodies say
The Undersea and Hyperbaric Medical Society lists 14 approved indications for HBOT. Delayed radiation injury is one of them, with a Level 1 evidence rating.
The American Society of Clinical Oncology (ASCO) acknowledges HBOT as a treatment option for radiation tissue injury in published guidelines.
Medicare's national coverage determination (NCD 20.29) covers HBOT for "soft tissue radionecrosis (osteoradionecrosis) as an adjunct to conventional treatment." Most commercial insurers in the US follow Medicare's lead.
This is a meaningful contrast with off-label HBOT uses. We unpack the broader pattern in our institutional silence on HBOT analysis.
Major medical centers use HBOT for radiation injury. They do not use it for off-label conditions.
Where to get HBOT for radiation injury
For an FDA-approved use like this one, UHMS-accredited hospital wound programs are the standard of care. Use the UHMS directory to find sites near you.
Hospital programs run hard-shell monoplace or multiplace chambers from Sechrist Industries or Perry Baromedical at 2.0 to 2.4 ATA. The chambers and protocols are standardized.
A wellness clinic running a soft-shell OxyHealth or Summit to Sea chamber at 1.3 ATA is not the right setting for this indication. Restore Hyper Wellness and similar chains explicitly do not market clinical wound services. Aviv Clinics does not market this indication either; its protocols are focused on aging and chronic conditions, not FDA-approved radiation injury care. See Aviv Clinics evidence vs. marketing for the marketing-vs-evidence breakdown.
The standard course is typically 30 to 40 sessions. If a clinic recommends 60+ sessions for radiation injury, ask for the justification. The published literature does not support routinely going past 40.
Cost and coverage
Medicare reimburses HBOT for radiation tissue injury under LCD L33718. The per-session reimbursement is typically $150-300 depending on locality.
Prior authorization is required. Documentation must show failure of conventional wound care, the radiation history, and clinical signs of radionecrosis.
Out-of-pocket cost without insurance for hard-shell HBOT is typically $250 to $500 per session. A 40-session course thus runs $10,000 to $20,000 without coverage.
Most patients with an established radiation injury diagnosis qualify for Medicare or commercial coverage. The administrative burden is real but the financial barrier is lower than for off-label uses.
Risks and contraindications
HBOT for radiation injury carries the same risk profile as other HBOT uses. The most common side effect is middle-ear barotrauma, affecting roughly 2% of sessions (Heyboer 2017).
Oxygen toxicity seizures are rare but real. The risk rises with longer sessions and higher pressures. Modern protocols include "air breaks" to reduce seizure risk.
Untreated pneumothorax is an absolute contraindication. Active malignancy is not automatically a contraindication, but each case requires careful evaluation by the treating oncologist.
For more detail, see our HBOT safety overview and the FDA's 2021 healthcare provider letter on chamber fire safety.
Specific patient scenarios
Several patterns come up often in clinical practice. We summarize them below.
Jaw bone injury after head and neck radiation. Standard care is gentle debridement plus 20-30 HBOT sessions. If that fails, surgery is added with 30 pre-op and 10 post-op sessions (Marx protocol).
Bleeding bladder after pelvic radiation. Two RCTs (Mathews 1999, Bennett 2009) show benefit. Protocol: 30 sessions at 2.0-2.4 ATA.
Bleeding rectum or bowel after pelvic radiation. Clarke 2008 supports HBOT here. Protocol similar to bladder.
Soft-tissue injury of breast or chest wall after breast cancer rays. Smaller evidence base than the above but covered under FDA approval. Protocol: 30-40 sessions.
HBOT before dental work in patients with prior radiation. The HOPON trial did not support this. Current practice is mixed; some centers still use it, others have stopped.
What to ask before booking
A few questions for any HBOT clinic before starting a radiation-injury course.
What is the chamber make and model? Hospital wound programs use FDA-cleared hard-shell chambers, typically Sechrist Industries or Perry Baromedical units. Look up the K-number on openFDA.
Is the program UHMS-accredited? Check the UHMS directory. For an FDA-approved use, accreditation matters more than for elective wellness use.
Who is the supervising physician? Look for UHMS or ABPM-certified hyperbaric physicians.
Will the program coordinate with your oncologist and the original radiation oncologist? Care coordination affects outcomes.
What is the expected session count and total cost? Get the answer in writing before starting.
Bottom line
If you have late-effect radiation tissue damage and you are weighing HBOT, the evidence supports a trial. Use a UHMS-accredited hospital wound program. Get prior authorization through Medicare or your commercial insurer.
The standard course is 30-40 sessions at 2.0-2.4 ATA. Soft-tissue and bone radionecrosis respond best. Prevention before dental work is less well supported.
This is one of the cleanest evidence cases in the HBOT field. The reason this article reads differently from our other HBOT coverage is that the underlying science is different.
Related Reading
- HBOT for burn recovery
- UHMS-accredited HBOT facilities: what certification means
- FDA-cleared hyperbaric chambers complete list
- HBOT 40-session protocol: why it's the standard
- Institutional silence on HBOT
Frequently asked questions
Is HBOT FDA-approved for radiation tissue damage?
Yes. Delayed radiation injury (soft tissue and bone) is one of the 13 FDA-approved HBOT indications. The Undersea and Hyperbaric Medical Society lists it as a Level 1 indication.
Does insurance cover HBOT for radiation injury?
Medicare covers it under LCD L33718. Most commercial insurers follow Medicare. Prior authorization is required, and documentation must show conventional wound care failure plus radiation history.
How many HBOT sessions are needed?
Standard protocol is 30 to 40 sessions at 2.0-2.4 ATA, 90 minutes each, five days a week. For dental work in irradiated tissue, the Marx protocol is 20 pre-op plus 10 post-op sessions.
Can I use a soft-shell wellness chamber for this?
No. Wellness chambers run at 1.3 ATA and are not FDA-cleared for medical treatment. Established radiation injury requires hard-shell chambers at clinical pressures in a UHMS-accredited program.
Where can I find UHMS-accredited radiation injury programs?
Check the UHMS directory. State-specific guides on our site list accredited sites for Texas, Florida, Virginia, New Jersey, and other major states.
Medical disclaimer: This article is informational and does not constitute medical advice. HBOT carries real risks including ear barotrauma, oxygen toxicity, and chamber fire. Discuss any HBOT plan with a doctor trained in undersea and hyperbaric medicine and your treating oncologist before starting. The FDA has cleared HBOT for delayed radiation tissue injury; coverage details vary by case and insurer.
-- The HBOT Finder Team